Decoy Therapeutics Inc. (DCOY) Net income 2016–2025
Decoy Therapeutics Inc. (DCOY) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$12.5MFY2025 · since FY2016: -$39.5M → -$12.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.5M | -124.5% |
| FY2024 | -$5.6M | +55.5% |
| FY2023 | -$12.5M | +60.3% |
| FY2022 | -$31.6M | -147.6% |
| FY2021 | -$12.8M | -73.7% |
| FY2020 | -$7.4M | -6.0% |
| FY2019 | -$6.9M | -315.4% |
| FY2018 | -$1.7M | +95.2% |
| FY2017 | -$34.4M | +12.8% |
| FY2016 | -$39.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DCOY financial trends
DCOY RevenueDCOY Net marginDCOY Gross profitDCOY Gross marginDCOY Operating incomeDCOY Operating marginDCOY Operating cash flowDCOY Free cash flowDCOY Capital expendituresDCOY Return on equityDCOY Stock buybacksDCOY Dividends paidDCOY Total assetsDCOY Total liabilitiesDCOY Shareholders’ equityDCOY overview →